Unknown

Dataset Information

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil.


ABSTRACT: The use of already-approved drugs to treat new or alternative diseases has proved to be beneficial in medicine, because it reduces both drug development costs and timelines. Most drugs can be used to treat different illnesses, due their mechanisms of action are not restricted to one molecular target, organ or illness. Diverging from its original intent offers an opportunity to repurpose previously approved drugs to treat other ailments. This is the case of sildenafil (Viagra), a phosphodiesterase-5 (PDE5) inhibitor, which was originally designed to treat systemic hypertension and angina but is currently commercialized as erectile dysfunction treatment. Sildenafil, tadalafil, and vardenafil are PDE5 inhibitors and potent vasodilators, that extend the physiological effects of nitric oxide an

SUBMITTER: Cruz-Burgos M 

PROVIDER: S-EPMC7952883 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature